124 related articles for article (PubMed ID: 213489)
21. Activation of the first component of human complement, C1, by monoclonal antibodies directed against different domains of subcomponent C1q.
Kilchherr E; Schumaker VN; Phillips ML; Curtiss LK
J Immunol; 1986 Jul; 137(1):255-62. PubMed ID: 3486914
[TBL] [Abstract][Full Text] [Related]
22. Role of C1 in the complement activating effect of Pseudomonas aeruginosa lipopolysaccharide preparations.
Füst G; Adám MM
Acta Microbiol Acad Sci Hung; 1976; 23(3):239-49. PubMed ID: 828439
[TBL] [Abstract][Full Text] [Related]
23. Activation of the alternative complement pathway by Leishmania promastigotes: parasite lysis and attachment to macrophages.
Mosser DM; Edelson PJ
J Immunol; 1984 Mar; 132(3):1501-5. PubMed ID: 6363545
[TBL] [Abstract][Full Text] [Related]
24. Failure of terminal complement components to induce lysis of Moloney virus transformed lymphocytes.
Cooper NR; Polley MJ; Oldstone MB
J Immunol; 1974 Feb; 112(2):866-8. PubMed ID: 4855965
[No Abstract] [Full Text] [Related]
25. Immune complex mediated activation of the classical complement pathway.
Borsos T
Behring Inst Mitt; 1989 Jul; (84):93-101. PubMed ID: 2478118
[TBL] [Abstract][Full Text] [Related]
26. Studies on the interactions between C-reactive protein and complement proteins.
Bíró A; Rovó Z; Papp D; Cervenak L; Varga L; Füst G; Thielens NM; Arlaud GJ; Prohászka Z
Immunology; 2007 May; 121(1):40-50. PubMed ID: 17244159
[TBL] [Abstract][Full Text] [Related]
27. Antibody-independent interactions between Escherichia coli J5 and human complement components.
Betz SJ; Isliker H
J Immunol; 1981 Nov; 127(5):1748-54. PubMed ID: 6795260
[TBL] [Abstract][Full Text] [Related]
28. Antibody-independent activation of C1. I. Differences in the mechanism of C1 activation by nonimmune activators and by immune complexes: C1r-independent activation of C1s by cardiolipin vesicles.
Kovacsovics TJ; Peitsch MC; Kress A; Isliker H
J Immunol; 1987 Mar; 138(6):1864-70. PubMed ID: 3029222
[TBL] [Abstract][Full Text] [Related]
29. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA
Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399
[TBL] [Abstract][Full Text] [Related]
30. Activation of C1r by proteolytic cleavage.
Ziccardi RJ; Cooper NR
J Immunol; 1976 Feb; 116(2):504-9. PubMed ID: 1249422
[TBL] [Abstract][Full Text] [Related]
31. Cytokines associated with amyloid plaques in Alzheimer's disease brain stimulate human glial and neuronal cell cultures to secrete early complement proteins, but not C1-inhibitor.
Veerhuis R; Janssen I; De Groot CJ; Van Muiswinkel FL; Hack CE; Eikelenboom P
Exp Neurol; 1999 Nov; 160(1):289-99. PubMed ID: 10630213
[TBL] [Abstract][Full Text] [Related]
32. A serum mannose-binding lectin mediates complement-dependent lysis of influenza virus-infected cells.
Reading PC; Hartley CA; Ezekowitz RA; Anders EM
Biochem Biophys Res Commun; 1995 Dec; 217(3):1128-36. PubMed ID: 8554567
[TBL] [Abstract][Full Text] [Related]
33. Activation of guinea pig C-type virus in cultured spleen cells by 5-bromo-2'-deoxyuridine.
Hsiung GD
J Natl Cancer Inst; 1972 Aug; 49(2):567-70. PubMed ID: 4342620
[No Abstract] [Full Text] [Related]
34. The mechanism of activation of the first component of complement by a univalent hapten-IgG antibody complex.
Goers JW; Ziccardi RJ; Schumaker VN; Glovsky MM
J Immunol; 1977 Jun; 118(6):2182-91. PubMed ID: 559020
[No Abstract] [Full Text] [Related]
35. C1 subcomponent complexes: basic and clinical aspects.
Laurell AB; Sjöholm AG
Behring Inst Mitt; 1993 Dec; (93):292-8. PubMed ID: 8172579
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of the hemolytic activity of the first component of complement C1 by an Escherichia coli C1q binding protein.
van den Berg RH; Faber-Krol MC; van de Klundert JA; van Es LA; Daha MR
J Immunol; 1996 Jun; 156(11):4466-73. PubMed ID: 8666822
[TBL] [Abstract][Full Text] [Related]
37. Trinitrophenylated red cells (E-TNP) as a model for antibody-independent activation of the complement system via the classical pathway.
Loos M; Thesen R
J Immunol; 1978 Jul; 121(1):24-8. PubMed ID: 670702
[TBL] [Abstract][Full Text] [Related]
38. Role of the complement system in antigen-induced bronchoconstriction and changes in blood pressure in the guinea pig.
Regal JF; Fraser DG; Toth CA
J Pharmacol Exp Ther; 1993 Nov; 267(2):979-88. PubMed ID: 8246173
[TBL] [Abstract][Full Text] [Related]
39. Lysis of RNA tumor viruses by human serum: direct antibody-independent triggering of the classical complement pathway.
Cooper NR; Jensen FC; Welsh RM; Oldstone MB
J Exp Med; 1976 Oct; 144(4):970-84. PubMed ID: 62019
[TBL] [Abstract][Full Text] [Related]
40. Activated guinea-pig C3 and the immune adherence receptor (a complement receptor) on cell membranes.
Okada H; Okada N
Immunology; 1975 Jun; 28(6):1165-71. PubMed ID: 1169221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
